Free
Virtual Hereditary Cancer Series

Virtual Hereditary Cancer Series

Actions and Detail Panel

Free

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
VIRTUAL HEREDITARY CANCER SERIES

About this event

Women's College Research Institute, with the Peter Gilgan Centre for Women's Cancers at Women's College Hospital in partnership with the Canadian Cancer Society, are continuing the virtual series of free one-hour seminars. This series will highlight the most relevant advances in hereditary breast and ovarian cancer research over the last several years, with a focus on topics that are important to women who carry a BRCA1 or BRCA2 mutation. The speakers include leaders in hereditary breast and ovarian cancer research and treatment. The series is running from January 2022 until November 2022.

Hosted by:

Hereditary Breast and Ovarian Cancer Research Unit at

Women's College Hospital

Dr. Steven Narod

Dr. Kelly Metcalfe

Dr. Joanne Kotsopoulos

Dr. Mohammad Akbari

Please note: All webinars are from 12:00PM-1:00PM.

Series Schedule

Friday, January 28

Dr. Steven Narod

Managing cancer risk after age 50

Dr. Steven Narod is a Canadian clinician-scientist who directs the Familial Breast Cancer Clinic at Women's College Hospital. He is a professor in the Dalla Lana School of Public Health at the University of Toronto. He is a senior scientist at Women’s College Research Institute, where he has led the Familial Breast Cancer Research Unit for the past 25 years. He has established an international study of 17,000 women with a BRCA1 or BRCA2 mutation. He has shaped our current knowledge of how to assess breast and ovarian cancer risk and how to reduce cancer mortality among carriers of BRCA1 and BRCA2 mutations, including screening, prevention, and treatment. With more than 900 publications, Dr. Narod is one of the most influential cancer researchers in the world.

Friday, February 25

Jeanna McCuaig, MSc, PhD, CGC, CCGC

Communicating with other family members

Jeanna is genetic counsellor working at the Familial Cancer Clinic at the Princess Margaret Cancer Centre. Jeanna received her MSc degree in genetic counselling from the University of Toronto in 2010, and her genetic counselling certification from both the Canadian Board of Genetic Counsellors (CBGC) and the American Board of Genetic Counseling (ABGC). Jeanna recently completed her PhD in the Lawrence S. Bloomberg Faculty of Nursing, working under the supervision of Dr. Kelly Metcalfe. Jeanna’s thesis work focused on evaluating health service and patient outcomes following Ontario’s implementation of reflex BRCA1/2 tumour genetic testing for all newly diagnosed high-grade serous ovarian cancers. She is an active member of the Canadian Association of Genetic Counsellors and continues to work to improve access to genetic testing in Canada by streamlining genetic counselling and testing processes.

Friday, April 29

Dr. Raymond Kim & Lauren Hughes

Who else is out there? The Ontario Hereditary Cancer Research Network – Patient driven research

Dr. Raymond Kim is a clinician-scientist with a large clinical practice specializing in hereditary cancer syndromes. He is the Medical Director of the Familial Cancer Clinic and Cancer Early Detection Program at Princess Margaret Cancer Centre, and a medical geneticist with Sinai Health System and the Hospital for Sick Children. Dr. Kim is leader of the Ontario Hereditary Cancer Research Network (OHCRN), Head of the Provincial Genetics Program at Ontario Health and Chair of the CCMG Canada-wide Cancer Genetics and Genomics (C2G2) community of practice. Dr. Kim received his MD/PhD from the University of Toronto in Medical Biophysics. He then completed a residency in Internal Medicine, followed by a fellowship in Medical Genetics at The Hospital for Sick Children. Dr. Kim’s research interests involve the integration of novel genomic technologies in clinical care including whole genome sequencing and cell free DNA.

Lauren is a genetic counsellor and the program manager of the Ontario Hereditary Cancer Research Network (OHCRN) at the Ontario Institute for Cancer Research (OICR). She received her MS degree in genetic counselling from the University of Michigan and has over a decade of experience in clinical genetics. While working in clinical care, she established a cancer genetics outreach clinic within a regional cancer centre, where she developed an interest in health equity and access – especially in the context of cancer genetics.

Friday, May 27

Dr. Kelly Metcalfe

Treatment of hereditary breast cancer

Dr. Kelly Metcalfe is a Professor in the Lawrence S. Bloomberg Faculty of Nursing and the Faculty of Medicine, Department of Surgery, at the University of Toronto and a Senior Scientist at the Women’s College Research Institute. She currently holds the Bloomberg Professorship in Cancer Genetics and is the Associate Dean of Research. Dr. Metcalfe received her BScN in 1996 from the University of Western Ontario, and her PhD in 2002 from the Institute of Medical Science at the University of Toronto. Dr. Metcalfe’s research focuses on the prevention and treatment of breast and ovarian cancer in high risk women, most specifically those with a BRCA1 or BRCA2 mutation. She has led international studies resulting in seminal research papers on the topic of treatment of BRCA-associated breast cancer. Dr. Metcalfe is using those research findings to test new models of care to ensure that women have access to genetic testing at the time of cancer diagnosis to make informed decisions about treatments.

Friday, June 24

Dr. Steven Narod, Dr. Marcus Bernardini, Dr. Andrea Eisen & Aletta Poll

Panel discussion/FAQ session with pre-submitted questions

Friday, September 23

Dr. Joanne Kotsopoulos

Considerations facing young women with a mutation

Dr. Joanne Kotsopoulos is a Scientist with the Familial Breast Cancer Research Unit at the Women’s College Research Institute, Women’s College Hospital and an Associate Professor at the University of Toronto. Dr. Kotsopoulos directs a wide-range of research initiatives to further our understanding of BRCA-associated breast and ovarian cancer, with the goal of identifying viable strategies that confer substantial risk reduction and improve outcomes. Her studies have demonstrated an important role of hormonal, reproductive and modifiable exposures on BRCA-associated cancer development. This critical work has provided women and healthcare providers with evidence-based management options while contributing to our understanding of the pathogenesis of hereditary cancer. Additional interests are aimed at identifying prognostic factors for ovarian cancer, a highly fatal disease, and furthering our understanding of how variation in treatment may impact outcomes.

Friday, October 28

Dr. Steven Narod

Pancreas, prostate, primary peritoneal

Dr. Steven Narod is a Canadian clinician-scientist who directs the Familial Breast Cancer Clinic at Women's College Hospital. He is a professor in the Dalla Lana School of Public Health at the University of Toronto. He is a senior scientist at Women’s College Research Institute, where he has led the Familial Breast Cancer Research Unit for the past 25 years. He has established an international study of 17,000 women with a BRCA1 or BRCA2 mutation. He has shaped our current knowledge of how to assess breast and ovarian cancer risk and how to reduce cancer mortality among carriers of BRCA1 and BRCA2 mutations, including screening, prevention, and treatment. With more than 900 publications, Dr. Narod is one of the most influential cancer researchers in the world.

Friday, November 25

Dr. Kelly Metcalfe & Dr. John Semple

Surgical prevention of hereditary breast cancer

Please note: The Eventbrite registration process will allow you to select one date at a time.

Please visit our website for more information on our Hereditary Breast and Ovarian Cancer Research Unit:

Women's College Research Institute

Share with friends

Location

Online event

Save This Event

Event Saved